PROCELL THERAPEUTICS INC.
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 04, 2017 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 59 Total Citation Count
- Jan 29, 2008 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9694087 Development of novel macromolecule transduction domain with improved cell permeability and method for using sameJan 15, 16Jul 04, 17[A61K, C12N, A61Q, C07K]
9259481 Development of novel macromolecule transduction domain with improved cell permeability and method for using sameNov 23, 12Feb 16, 16[A61K, C12N, A61Q, C07K]
9040477 Macromolecule transduction domains and methods for identification and uses thereofNov 27, 13May 26, 15[A61K, C07K]
8629097 Macromolecule transduction domains and methods for identification and uses thereofJan 29, 08Jan 14, 14[C07K]
8470971 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredientDec 02, 09Jun 25, 13[C07K]
8450279 Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the sameSep 04, 08May 28, 13[C12N]
8445443 Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the sameSep 04, 08May 21, 13[C12N]
8158415 Combined use of cell permeable Nanog and Oct4 for increasing self-renewal and suppressing differentiation of stem cellsFeb 27, 08Apr 17, 12[C07H, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0095,188 ESTABLISHMENT OF INDUCED PLURIPOTENT STEM CELL USING CELL-PERMEABLE REPROGRAMMING TRANSCRIPTION FACTOR FOR CUSTOMIZED STEM CELL THERAPYAbandonedMar 12, 10Apr 19, 12[C12P, C12N, C07K]
2011/0021,442 CELL PREAMBLE RUNX3 RECOMBINANT PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME, AND ANTICANCER COMPOSITIONS INCLUDING THE SAMEAbandonedNov 06, 08Jan 27, 11[A61K, C07H, C12P, C12N, A61P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.